Our Impact
GLP-1 therapies are transforming the future of healthcare and so are we.
At the GLP-1 Collective, we are leading efforts to expand access, raise awareness, and build a healthier tomorrow. Explore our journey, our current initiatives, and the future we’re shaping — and see how your support can drive lasting change.
Our History
See Our Timeline
Since our founding, the GLP-1 Collective has been united by a single mission: making prescribed GLP-1 medications more accessible for everyone who needs them.
From grassroots efforts to growing national momentum, our milestones reflect the strength of a community working together — patients, providers, advocates, and partners — to improve access and empower individuals.
We're committed to breaking down barriers and helping shape a more inclusive, supportive, and affordable path forward in healthcare.
-
In November of 2024 we launched a petition to fight for affordable access to GLP-1s
-
Our petition was featured in the Politico highlighting the ongoing shortage and the challenge of tracking the full number of GLP-1 patients.
-
In November our petition was featured in USA Today, highlighting the fight for affordable GLP-1s and the role of compounding pharmacies in expanding access.
-
In December, our founder was featured on ABC’s Local 5 News, highlighting our petition and the vital role of compounding pharmacies in affordable GLP-1 access.
-
In December, our petition was featured in a CNBC article, this time highlighting the urgent need for preventive care, and how current insurance coverage often only begins after patients are already in crisis.
-
In December, we launched the GLP-1 Collective Podcast. This is a platform where brand-name and compound users share personal stories about how these medications have been both life-changing and life-saving.
-
In early January, the GLP-1 Collective officially registered as a nonprofit, centralizing our advocacy efforts, building a membership platform, and deepening our commitment to affordable access for all.
-
In February, the GLP-1 Collective was officially recognized as a 501(c)(3) tax-exempt charitable nonprofit, retroactive to January 10, 2025.
This was a major milestone in our mission to fight for affordable access. -
In March, the GLP-1 Collective was featured in USA Today, underscoring the growing crisis as compounded GLP-1 options vanish, driving up costs and reducing access for patients who depend on affordable alternatives.
-
-
Current Programs
What We're Building Now
Today, we are actively supporting patients and working to expand access through a range of collaborative, community-based programs:
Support Groups: Creating safe spaces for patients to connect, share experiences, and build community around GLP-1 treatment journeys.
Educational Resources: Offering webinars, expert Q&As, infographics, and online guides to help patients better understand their prescribed care and treatment options.
Advocacy Campaigns: Raising awareness and working with partners to support thoughtful policy changes that improve affordability and access.
Healthcare Network Expansion: Building partnerships with clinics, physicians, and healthcare organizations to strengthen patient pathways and access to care.
Each initiative brings us one step closer to a more informed, connected, and supported patient community.
Future Initiatives
New approvals. New hope. No barriers.
We’re just getting started. As GLP-1 medications expand into new indications—like weight management, cardiovascular health, and the treatment of chronic conditions—the need for coordinated, patient-centered advocacy is more important than ever.
Looking Ahead, Our Priorities Include:
Educational Outreach: Launching a nationwide campaign with expert-led content to raise awareness and improve access to reliable, science-based information that supports informed decisions between patients and providers.
A Health Access Expo: A national event bringing together patients, providers, researchers, and healthcare partners to spotlight innovation, progress, and shared solutions for access and affordability.
Policy Advocacy: Supporting legislative efforts that promote affordability, transparency, and expanded access to medically appropriate GLP-1 therapies — in partnership with all stakeholders working toward better care.
Community Building: Establishing local chapters and hosting regional events to foster connection, peer support, and shared impact across communities navigating prescribed GLP-1 treatment.
